{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:22:04Z","timestamp":1770333724217,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Florida Office of the State Courts Administrator"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction and Aims<\/jats:title><jats:p>People with opioid use disorder are prevalent in criminal problem\u2010solving courts and dependency courts, which have rehabilitative aims. Medication for opioid use disorder (MOUD) is the standard of care. Court staff set treatment policies for court clients. They may receive training from MOUD manufacturers, but no studies have examined court staff receipt of such training.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Methods<\/jats:title><jats:p>To examine receipt of training from MOUD manufacturers, we designed a cross\u2010sectional survey for court staff. We distributed it online to all Florida court staff in criminal problem\u2010solving or dependency courts (<jats:italic>n<\/jats:italic> = 585). Outcome variables were receipt of training from one or more MOUD manufacturers and training source. Covariates included dichotomous measures of court type, staff role, gender and rurality. Logistic regression models estimated the relationship between receipt of training and covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010one percent of Florida criminal problem\u2010solving and dependency court staff completed the survey. The most common receipt of training was from the manufacturer of extended\u2010release naltrexone (36%), followed by buprenorphine (24%) and methadone (11%). Fifty\u2010seven percent of those who received training received it from more than one MOUD manufacturer. Criminal problem\u2010solving court staff were more likely than dependency court staff to receive training from MOUD manufacturers. Court program co\u2010ordinators were more likely than other staff roles to receive training from MOUD manufacturers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>A large minority of respondents received training from a MOUD manufacturer, primarily from extended\u2010release naltrexone's manufacturer, raising concerns regarding information accuracy and conflicts of interest. Court staff should seek MOUD training from academic institutions and non\u2010profit organisations instead.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13090","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:55:29Z","timestamp":1589244929000},"page":"583-587","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem\u2010solving and dependency court staff"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6369","authenticated-orcid":false,"given":"Barbara","family":"Andraka\u2010Christou","sequence":"first","affiliation":[{"name":"Department of Health Management and Informatics University of Central Florida  Orlando USA"},{"name":"Department of Internal Medicine (Joint Secondary Appointment) University of Central Florida  Orlando USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Health Management and Informatics University of Central Florida  Orlando USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Madeira","sequence":"additional","affiliation":[{"name":"Maurer School of Law Indiana University  Bloomington USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross D.","family":"Silverman","sequence":"additional","affiliation":[{"name":"Richard M. Fairbanks School of Law Indiana University  Indianapolis USA"},{"name":"Robert H. McKinney School of Law Indiana University  Indianapolis USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"e_1_2_8_3_1","volume-title":"Medications for opioid use disorder TIP 63 treatment improvement protocol for healthcare and addiction professionals, policymakers, patients, and families","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"e_1_2_8_4_1","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"9","author":"Nielsen S","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_5_1","volume-title":"WHO\/UNODC\/UNAIDS position paper. Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention","author":"World Health Organization","year":"2004"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.10.004"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.0890"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.06.011"},{"key":"e_1_2_8_9_1","volume-title":"Family treatment court best practice standards","author":"Center for Children and Family Futures and National Association of Drug Court Professionals","year":"2019"},{"key":"e_1_2_8_10_1","volume-title":"Painting the current picture: a national report on drug courts and other problem\u2010solving courts in the United States","author":"Marlowe DB","year":"2016"},{"key":"e_1_2_8_11_1","first-page":"189","article-title":"What is treatment for opioid addiction in problem\u2010solving courts? A study of 20 Indiana drug & veterans courts","volume":"13","author":"Andraka\u2010Christou B","year":"2017","journal-title":"Stan J Civil Rights Civil Liberties"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-015-9972-3"},{"key":"e_1_2_8_13_1","volume-title":"2018\u20132019 early childhood court evaluation interim report to the Office of Court Improvement","author":"Magruder L","year":"2019"},{"key":"e_1_2_8_14_1","volume-title":"Best practice standards","author":"Florida Adult Drug Court","year":"2017"},{"key":"e_1_2_8_15_1","volume-title":"Adult drug court best practice standards","author":"National Association of Drug Court Professionals","year":"2015"},{"key":"e_1_2_8_16_1","unstructured":"National Association of Drug Court Professionals. Adult drug courts: Best practice standards Volume II. 2015. Available at: https:\/\/www.nadcp.org\/wp\u2010content\/uploads\/2018\/12\/Adult\u2010Drug\u2010Court\u2010Best\u2010Practice\u2010Standards\u2010Volume\u20102\u2010Text\u2010Revision\u2010December\u20102018.pdf. (accessed May 2020)."},{"key":"e_1_2_8_17_1","unstructured":"HarperJ.To grow market share a drugmaker pitches its product to judges. National Public Radio 2017."},{"key":"e_1_2_8_18_1","volume-title":"Experience management platform","author":"Qualtrics","year":"2018"},{"key":"e_1_2_8_19_1","volume-title":"Stata statistical software: release 14","author":"StataCorp LP","year":"2015"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.13090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13090","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:02:53Z","timestamp":1693951373000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/dar.13090"],"URL":"https:\/\/doi.org\/10.1111\/dar.13090","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"2020-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}